FHA
ORGO icon

Flagship Harbor Advisors’s Organogenesis Holdings ORGO Stock Holding History

Flagship Harbor Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,500
Closed -$33.7K – 1712
2025
Q4 		$33.7K Buy
+6,500
New +$31.5K ﹤0.01% 1175
2021
Q2 		– Sell
-34,000
Closed -$619K – 669
2021
Q1 		$619K Buy
+34,000
New +$461K 0.07% 298

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Flagship Harbor Advisors's ORGO Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 6,500 shares — an estimated $33.7K sold.

Flagship Harbor Advisors first reported a position in ORGO in Q1 2021 and held it in 2 quarters. The position peaked at $619K in Q1 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 6,500 Organogenesis Holdings shares in Q1 2026, an estimated $33.7K.
  • Flagship Harbor Advisors first reported a position in Organogenesis Holdings in Q1 2021 and held it in 2 quarters.
  • Flagship Harbor Advisors's Organogenesis Holdings position peaked at $619K in Q1 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.